Commentary · 21 Feb 2026
Conference abstractPublished 28 Sep 2015
What kinase gene expressed differently in primary and metastatic kidney cancer
1Department of Radiation Oncology 2Department of Medicine University of Alabama, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Systemic treatment for metastatic clear cell (CC)-renal cell cancer (RCC) produces a median survival of only 1-2 years. Although understanding of biology leading to better treatments will likely require analysis of metastatic tumor tissue, most studies have analyzed the primary kidney tumor. We planned to study both primary and metastatic tumors to identify new kinase genes expressed in metastatic tumors compared to primary kidney tumors. These data may enable the design of new drugs, since it is relatively easier to design kinase inhibitors. Methods: Samples of primary tumor, adjacent normal kidney, and metastatic tumor from 18 patients were available. RNA from samples was analyzed by Nanostring for levels of expression of 519 kinase genes. Over-expression was defined as >2-fold elevation compared to reference genes. Results: Some of the top genes overexpressed in metastases compared to primary tumor and normal kidney were ROS1, EPHA3, PLK1 and CDK1. Some genes were under-expressed in tumors compared to normal kidney, suggesting that some kinase genes could protect against tumor growth. Conclusions: We identified many genes overexpressed in metastatic CC-RCC tumor tissue, which may represent drivers of metastasis and targets for new drugs. Confirmation of findings is required before clinical trials of new drugs.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Amy Zhao”
- BylineArticles whose byline prints “Arjun Guru”
- BylineArticles whose byline prints “Guru Sonpavde”
- BylineArticles whose byline prints “Tiffiny Cooper”
- BylineArticles whose byline prints “Dongquan Chen”
- BylineArticles whose byline prints “Eddy Yang”
